| Literature DB >> 25360794 |
Jennifer Vandooren1, Benjamin Born2, Inna Solomonov2, Ewa Zajac3, Radka Saldova4, Michael Senske2, Estefanía Ugarte-Berzal5, Erik Martens1, Philippe E Van den Steen1, Jo Van Damme6, Angeles Garcia-Pardo5, Matheus Froeyen7, Elena I Deryugina3, James P Quigley3, Søren K Moestrup8, Pauline M Rudd4, Irit Sagi2, Ghislain Opdenakker1.
Abstract
Gelatinase B/matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) cleaves many substrates and is produced by most cell types as a zymogen, proMMP-9, in complex with the tissue inhibitor of metalloproteinases-1 (TIMP-1). Natural proMMP-9 occurs as monomers, homomultimers and heterocomplexes, but our knowledge about the overall structure of proMMP-9 monomers and multimers is limited. We investigated biochemical, biophysical and functional characteristics of zymogen and activated forms of MMP-9 monomers and multimers. In contrast with a conventional notion of a dimeric nature of MMP-9 homomultimers, we demonstrate that these are reduction-sensitive trimers. Based on the information from electrophoresis, AFM and TEM, we generated a 3D structure model of the proMMP-9 trimer. Remarkably, the proMMP-9 trimers possessed a 50-fold higher affinity for TIMP-1 than the monomers. In vivo, this finding was reflected in a higher extent of TIMP-1 inhibition of angiogenesis induced by trimers compared with monomers. Our results show that proMMP-9 trimers constitute a novel structural and functional entity that is differentially regulated by TIMP-1.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25360794 PMCID: PMC4399976 DOI: 10.1042/BJ20140418
Source DB: PubMed Journal: Biochem J ISSN: 0264-6021 Impact factor: 3.857